21Shares Submits Revised INJ Spot ETF Filing to U.S. SEC

Asset manager 21Shares has filed a revised S-1 form for an INJ spot ETF with the U.S. Securities and Exchange Commission (SEC) on April 18 (local time), according to CryptoBriefing. The proposed ETF, if approved, would trade on Nasdaq under the ticker 'TINJ' and track the FTSE Injective Index. The strategy also includes a feature allowing the fund manager to stake some of its INJ holdings for yield rewards. However, this filing does not guarantee approval, as final approval will be determined after SEC review.

As of CoinMarketCap data, INJ is currently trading at $6.59, up 14.98% from its previous price.